Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180103038196N5Phase 3Completed
Phase 3 trial of metformin and human insulin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoint: Postpartum oral glucose tolerance test result. Started May 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180103038196N5.